Authors: Mulherkar, R

Citation: R. Mulherkar, Gene therapy for cancer, CURRENT SCI, 81(5), 2001, pp. 555-560

Authors: Papanikolaou, A Wang, QS Mulherkar, R Bolt, A Rosenberg, DW

Citation: A. Papanikolaou et al., Expression analysis of the group IIA secretory phospholipase A(2) in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis, CARCINOGENE, 21(2), 2000, pp. 133-138

Authors: Kadam, S Mulherkar, R

Citation: S. Kadam et R. Mulherkar, Enhancing activity and phospholipase A(2) activity: two independent activities present in the enhancing factor molecule, BIOCHEM J, 340, 1999, pp. 237-243

Authors: Deshpande, C Patki, V Deo, MG Mulherkar, R

Citation: C. Deshpande et al., Expression of enhancing factor/phospholipase A(2) in ICRC mice, J BIOSCI, 24(1), 1999, pp. 21-26

Authors: Cupillard, L Mulherkar, R Gomez, N Kadam, S Valentin, E Lazdunski, M Lambeau, G

Citation: L. Cupillard et al., Both group IB and group IIA secreted phospholipases A(2) are natural ligands of the mouse 180-kDa M-type receptor, J BIOL CHEM, 274(11), 1999, pp. 7043-7051

Authors: Thomas, SM Naresh, KN Wagle, AS Mulherkar, R

Citation: Sm. Thomas et al., Preclinical studies on suicide gene therapy for head/neck cancer: A novel method for evaluation of treatment efficacy, ANTICANC R, 18(6A), 1998, pp. 4393-4398